Shift Bioscience (Shift), a biotech company using an AI powered virtual cell to fight age-driven diseases, today announced ...

Shift Bioscience (Shift), a biotech company using an AI-powered virtual cell to fight age-driven diseases, appointed Lord ...

Cambridge biotech company Shift Bioscience, which is using an AI powered virtual cell to fight age-driven diseases, has ...

Here is a brief rundown of some coming entertainment options in Northeast Ohio. Make submissions for consideration via email to entertainment@morningjournal.com or entertainment@news-herald.com. You ...

Dan Ives, Wedbush Securities, and Bryn Talkington, Requisite Capital, join 'Closing Bell' to discuss Elon Musk's interview ...

The announcement of the 90-day tariff pause with China turned into a boon for tech stocks, as the indexes spiked higher. One ...

Tech analyst Dan Ives offers a candid assessment of Tesla as demand pressures mount and investor attention shifts toward its ...

CNBC’s Jim Cramer lauded the artificial intelligence deals announced after the U.S.-Saudi Investment Forum and touted Gulf countries to be future hyperscalers. What Happened: According to an X ...

Wedbush analyst Daniel Ives said. The theme was clear in Riyadh: the AI Revolution is coming to the Saudi Kingdom, and Riyadh will be a major buyer of AI chips, software, autonomous robotics ...

Wedbush analyst Daniel Ives has been constantly discussing the AI Revolution over the past few years. This is because he believes that this industry exhibits the biggest tech transformation in ...

Wedbush analyst Daniel Ives has been constantly discussing the AI Revolution over the past few years. This is because he believes that this industry exhibits the biggest tech transformation in ...

This morning is a huge win for the bulls and a best case scenario post this weekend in our view,” Daniel Ives, global head of technology research at Wedbush Securities, said in a note on Monday.